Cargando…

Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis

Metastasis is the main cause of death for cancer patients. Targeting factors that control metastasis formation is a major challenge for clinicians. Lysophosphatidic acid (LPA) is a bioactive phospholipid involved in cancer. LPA activates at least six independent G protein-coupled receptors (LPA(1–6)...

Descripción completa

Detalles Bibliográficos
Autores principales:	DAVID, MARION, RIBEIRO, JOHNNY, DESCOTES, FRANÇOISE, SERRE, CLAIRE-MARIE, BARBIER, MARYSE, MURONE, MAXIMILIEN, CLÉZARDIN, PHILIPPE, PEYRUCHAUD, OLIVIER
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584523/ https://www.ncbi.nlm.nih.gov/pubmed/22200658 http://dx.doi.org/10.3892/ijo.2011.1309

Ejemplares similares

Identification of Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Biomarker for Lysophosphatidic Acid Receptor Type 1 (LPA(1)) Activation in Human Breast and Prostate Cancers
por: David, Marion, et al.
Publicado: (2014)

Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts
por: David, Marion, et al.
Publicado: (2010)

Lysophosphatidic Acid Enhances Stromal Cell-Directed Angiogenesis
por: Binder, Bernard Y. K., et al.
Publicado: (2013)

Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders
por: Alioli, Candide, et al.
Publicado: (2022)

The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer
por: Sahay, Debashish, et al.
Publicado: (2015)

DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death
por: Thibault, Benoît, et al.
Publicado: (2018)

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)
por: Softic, Laurent, et al.
Publicado: (2020)

SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells
por: Langdon, Casey G., et al.
Publicado: (2015)

The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate
por: Bobardt, Michael, et al.
Publicado: (2019)

Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination
por: Klymenko, Yuliya, et al.
Publicado: (2020)

Fallo que paralizó máquina del "Big Bang" se debió a un error humano
Publicado: (2008)

El fallo en el acelerador se debió muy probablemente a un error humano
Publicado: (2008)

El fallo en el acelerador se debió muy probablemente a un error humano
Publicado: (2008)

Electrochemically derived nanographene oxide activates endothelial tip cells and promotes angiogenesis by binding endogenous lysophosphatidic acid
por: Liu, Wenjing, et al.
Publicado: (2021)

El colapso de la máquina del 'Big Bang' se debió a un error humano
Publicado: (2008)

IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition
por: Alicke, Bruno, et al.
Publicado: (2022)

The Role of Lysophosphatidic Acid in Adult Stem Cells
por: Lee, Dongjun, et al.
Publicado: (2020)

Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study
por: Hurwitz, Herbert I., et al.
Publicado: (2015)

Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer
por: Gomez‐Roca, Carlos, et al.
Publicado: (2021)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
por: Yu, Zi-Li, et al.
Publicado: (2018)

Expression of Lysophosphatidic Acid Receptor 1 and Relation with Cell Proliferation, Apoptosis, and Angiogenesis on Preneoplastic Changes Induced by Cadmium Chloride in the Rat Ventral Prostate
por: Arriazu, Riánsares, et al.
Publicado: (2013)

The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice
por: Bobardt, Michael, et al.
Publicado: (2020)

Modulation of cell surface fibronectin assembly sites by lysophosphatidic acid
Publicado: (1994)

Lysophosphatidic acid enhances breast cancer cells-mediated osteoclastogenesis
por: Nam, Ju-Suk, et al.
Publicado: (2018)

Role of lysophosphatidic acid in proliferation and differentiation of intestinal epithelial cells
por: Konno, Tasuku, et al.
Publicado: (2019)

Lysophosphatidic Acid and Glutamatergic Transmission
por: Roza, Carolina, et al.
Publicado: (2019)

Lysophosphatidic Acid Signaling in Cancer
por: Brindley, David N.
Publicado: (2020)

Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model
por: Bellaye, Pierre-Simon, et al.
Publicado: (2018)

EPCT-07. DEBIO1347, AN ORAL FGFR INHIBITOR: RESULTS FROM A SINGLE CENTER STUDY IN RECURRENT/REFRACTORY FGFR ALTERED PEDIATRIC GLIOMAS
por: Sait, Sameer Farouk, et al.
Publicado: (2020)

EPCT-10. DEBIO1347, AN ORAL FGFR INHIBITOR: RESULTS FROM A SINGLE CENTER STUDY IN RECURRENT/REFRACTORY FGFR ALTERED PEDIATRIC GLIOMAS
por: Farouk Sait, Sameer, et al.
Publicado: (2021)

Diabetes Disrupts the Response of Retinal Endothelial Cells to the Angiomodulator Lysophosphatidic Acid
por: Aranda, Jorge, et al.
Publicado: (2012)

Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells
por: Sui, Yanxia, et al.
Publicado: (2015)

Lysophosphatidic Acid Is a Proinflammatory Stimulus of Renal Tubular Epithelial Cells
por: Magkrioti, Christiana, et al.
Publicado: (2022)

Lysophosphatidic acid in carcinogenesis and tumor development
por: Albrecht, Wiebke
Publicado: (2018)

Regulation of Tumor Immunity by Lysophosphatidic Acid
por: Lee, Sue Chin, et al.
Publicado: (2020)

Lysophosphatidic Acid Signaling in Diabetic Nephropathy
por: Lee, Jong Han, et al.
Publicado: (2019)

Fibroblastic reticular cell-derived lysophosphatidic acid regulates confined intranodal T-cell motility
por: Takeda, Akira, et al.
Publicado: (2016)

Lysophosphatidic Acid Disrupts Junctional Integrity and Epithelial Cohesion in Ovarian Cancer Cells
por: Liu, Yueying, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dhgdu5em4cc0g5gmfgk6c2a87c